Navigation Links
Reportlinker Adds Spain Pharmaceutical Market Overview - Price cuts set to negatively impact both branded and generics companies
Date:1/11/2011

NEW YORK, Jan. 11, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Spain Pharmaceutical Market Overview – Price cuts set to negatively impact both branded and generics companies

http://www.reportlinker.com/p0360216/Spain-Pharmaceutical-Market-Overview – Price-cuts-set-to-negatively-impact-both-branded-and-generics-companies.html

IntroductionThe Spanish prescription pharmaceutical market was valued at $22.1bn in sales in 2009, with an annual growth rate of 6.4% between 2008 and 2009. Key growth drivers include growing use of chronic high-value innovative treatments driven by an aging population, with a high proportion of healthcare expenditure spent on prescription pharmaceuticals.

Features and benefits

* Overview of socioeconomic and demographic trends, healthcare system, regulation, pricing and reimbursement and intellectual property in Spain

* Assesses the size of the Spanish pharmaceutical market by prescribing setting, therapy area, leading brands and by leading companies

* Examines the Spanish generics and biosimilars landscape in terms of regulatory issues, level of penetration, key players and degree of brand erosion

* Quantifies the R&D and manufacturing infrastructure for the leading pharmaceutical companies, including key metrics and domestic M&A analysis

HighlightsFor newly patented drugs, when deciding on the reimbursement price, the CIPM evaluates a number of factors, including the cost of manufacturing and research and development, cost per day compared with equivalent products in Spain, sales forecast, expected impact on the SNS budget and the product's price in other low-cost European countries.

The Introduction of reference pricing in Spain during 2000, numerous rounds of price cuts, the low price differential between brands and generics, and insufficient physician incentives and the lack of requirement to prescribe by International Non proprietary Name has limited generic penetration as well as the profit potential of generics players.

The Spanish government is trying to restore confidence in the Spanish pharmaceutical market and is working on a strategic plan to develop its sector through increased investment and job creation. Nevertheless, this is still in the early stages and details are yet to be announced.

Your key questions answered* Evaluate the evolving regulatory landscape and the impact of pricing and reimbursement controls on market access in Spain

* Quantify the size and growth of the prescription pharmaceutical market in Spain, analyzing key therapy areas, brands and companies

* Assess drivers and resistors of generic and biosimilars uptake in Spain

To order this report:: Spain Pharmaceutical Market Overview – Price cuts set to negatively impact both branded and generics companies

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Forecast Insight: Antihypertensives - Fixed-dose combinations fail to offset generic erosion
2. Reportlinker Adds Germany Pharmaceutical Market Overview - New pricing rules set to negatively impact drug sales both domestically and internationally
3. Reportlinker Adds The Endoscopy Device Market Outlook to 2015
4. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
5. Reportlinker Adds Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
6. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
7. Reportlinker Adds Johnson & Johnson: PharmaVitae Profile
8. Reportlinker Adds France Pharmaceutical Market Overview - Austerity measures will impact pharmaceutical market growth
9. Reportlinker Adds Innovative Drug Discovery in Emerging Markets
10. Reportlinker Adds Chugai Pharmaceutical Co., Ltd: PharmaVitae Profile
11. Reportlinker Adds Cosmetic Surgery Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 24, 2016 , ... Southern Illinois University School of Dental ... Illinois State Dental Society (ISDS) Foundation’s Mission of Mercy (MOM). They will host ... Collinsville. , They expect to treat approximately 2,000 patients from Illinois, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... a not-for-profit organization responsible for clinical transfusion research programs and for the blood ... Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) study. , Currently ...
(Date:6/23/2016)... ... June 23, 2016 , ... SyncDog, Inc. , ... security software, is featured in the current issue of Silicon Review ... with innovative technology solutions and features them in their magazine. The magazine allows ...
(Date:6/23/2016)... ... 23, 2016 , ... Horizon Blue Cross Blue Shield of ... from the crushing burden of sky-high health care costs, Superior Court of New ... ( http://www.judiciary.state.nj.us/opinions/a2913-15a2929-15.pdf ) the court provided some analysis of the contracts between ...
(Date:6/23/2016)... ... ... A key metric of this success is the popularity of the Leafedin.org service ... areas that lack the kind of technology and networking framework that LeafedIn.org provide, where ... the marijuana industry, no matter how small or large, and more importantly no matter ...
Breaking Medicine News(10 mins):